High blood pressure trials in China

In China 127 Also abroad 843

127 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Adaptive Intervention Model for Hypertension Self-Management in Rural Areas: A Doctor-Patient Interaction Approach
Where
Chengdu
Age
18 years to 80 years
People
320
Run by
Yuju Wu
See details and how to joinNCT06869031
No phaseNot yet taking people in China
A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Renal Artery Stenting Among Atherosclerosis Renal-vascular Hypertension Patients
Where
Beijing
Age
18 years and over
People
200
Run by
Peking University First Hospital
See details and how to joinNCT07111442
No phaseNot yet taking people in China
Laparoscopic Adventitial Renal Denervation (RDN) for Refractory Hypertension
Where
Zhengzhou
Age
18 years to 65 years
People
10
Run by
Henan Institute of Cardiovascular Epidemiology
See details and how to joinNCT07108829
No phaseTaking people
Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients
Where
Xi'an
Age
18 years to 80 years
People
1,200
Run by
Xijing Hospital
See details and how to joinNCT06558877
No phaseTaking people
County Medical Community-based, Cardiovascular Risk Stratified Integrated Care Model: a Pragmatic Cluster Randomised Control Trial
Where
Liuzhou, Sanming
Age
40 years to 70 years
People
2,560
Run by
Peking University
See details and how to joinNCT06302127
No phaseTaking people
To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension
Where
Beijing, Chengdu, Chongqing, Hangzhou, Hohhot, Jinan, Lanzhou, Shanghai, Shenzhen, Xiamen, Xi’an, Xining, Yinchuan, Zhengzhou
Age
18 years to 75 years
People
213
Run by
Lepu Medical Technology (Beijing) Co., Ltd.
See details and how to joinNCT07051811
No phaseEnrolling by invitation
Serum miR-455-5p and Cardiac Structure and Function Parameters in Patients With Hypertensive Heart Disease
Where
Shenzhen
Age
18 years and over
People
46
Run by
The University of Hong Kong-Shenzhen Hospital
See details and how to joinNCT07033676
No phaseTaking people
Safety of Etomidate-propofol Mixture vs. Propofol for Total Intravenous Anesthesia in Elderly Patients Undergoing Abdominal Surgery
Where
Wuhan
Age
65 years to 80 years
People
166
Run by
Tongji Hospital
See details and how to joinNCT07019246
No phaseTaking people
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
Where
Nantong
Age
30 years and over
People
300
Run by
Affiliated Hospital of Nantong University
See details and how to joinNCT06935513
No phaseNot yet taking people in China
Intervention Study on Digital Health Management
Where
Shanghai
Age
18 years to 65 years
People
300
Run by
Shanghai 10th People's Hospital
See details and how to joinNCT06949306
No phaseNot yet taking people in China
Etiological Classification-guided Individual Intervention in Primary Hypertension
Where
Shanghai
Age
18 years to 65 years
People
2,000
Run by
Shanghai 10th People's Hospital
See details and how to joinNCT06941935
Phase 3Enrolling by invitation
A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents
Where
Linyi
Age
6 years to 17 years
People
342
Run by
Shandong New Time Pharmaceutical Co., LTD
See details and how to joinNCT06863987
No phaseTaking people
Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
Where
Jiangse, Shanghai
Age
18 years to 80 years
People
480 worldwide
Run by
Istituto Auxologico Italiano
See details and how to joinNCT03206814
Phase 4Taking people
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
Where
Beijing, Bengbu, Bozhou, Chengdu, Chizhou, Deyang, Fuyang, Ganzhou, Guiyang, Huaihua, Lianyungang, Loudi, Luzhou, Nanchang, Weinan, Yancheng, Yangjiang, Zaozhuang
Age
45 years to 74 years
People
32,000
Run by
Shenzhen Ausa Pharmed Co.,Ltd
See details and how to joinNCT04974138
Phase 4Taking people
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
Where
Beijing, Bengbu, Bozhou, Chengdu, Chizhou, Deyang, Fuyang, Ganzhou, Guiyang, Huaihua, Lianyungang, Loudi, Luzhou, Nanchang, Weinan, Yancheng, Yangjiang, Zaozhuang
Age
45 years to 74 years
People
24,000
Run by
Shenzhen Ausa Pharmed Co.,Ltd
See details and how to joinNCT04974151
No phaseNot yet taking people in China
SMART Study in Real World
Where
Beijing
Age
18 years and over
People
1,000
Run by
SyMap Medical (Suzhou), Ltd.
See details and how to joinNCT06780696
No phaseTaking people
Clinical Analysis of the Antihypertensive Effect of Laparoscopic Peripheral Nerve Blockade of the Renal Artery in Patients With Retroperitoneal Disease and Hypertension
Where
Shanghai
Age
18 years to 75 years
People
246
Run by
Ruijin Hospital
See details and how to joinNCT06829134
No phaseTaking people
Effect of Bariatric Surgery on Cardiac Function in Patients With Hypertension
Where
Beijing
Age
17 years to 70 years
People
40
Run by
Beijing Friendship Hospital
See details and how to joinNCT05166954
No phaseTaking people
Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
Where
Beijing
Age
18 years to 70 years
People
180
Run by
Beijing Friendship Hospital
See details and how to joinNCT05498675
No phaseNot yet taking people in China
Standardized Antihypertensive Treatment Protocol
Where
Shanghai
Age
18 years to 80 years
People
400
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06790927
Phase 4Not yet taking people in China
Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage
Where
Beijing
Age
18 years to 80 years
People
532
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT06760078
No phaseTaking people
A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"
Where
Shanghai
Age
18 years to 80 years
People
10,000
Run by
Yan Li
See details and how to joinNCT03547856
No phaseTaking people
Registry Study on "Control Nocturnal Hypertension to Reach the Target "
Where
Shanghai
Age
50 years to 79 years
People
4,500
Run by
Shanghai Institute of Hypertension
See details and how to joinNCT04137549
Phase 4Taking people
Morning Versus Bedtime Dosing of Antihypertensive Medication
Where
Shanghai
Age
18 years to 70 years
People
300
Run by
Yan Li
See details and how to joinNCT05089448
Phase 3Not yet taking people in China
QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension
Where
Beijing
Age
18 years to 75 years
People
810
Run by
Wuhan Createrna Science and Technology Co., Ltd
See details and how to joinNCT06716970